Literature DB >> 22198376

Retinal dysfunction, photoreceptor protein dysregulation and neuronal remodelling in the R6/1 mouse model of Huntington's disease.

Abrez Hussain Batcha1, Una Greferath, Andrew I Jobling, Kirstan A Vessey, Michelle M Ward, Jess Nithianantharajah, Anthony J Hannan, Michael Kalloniatis, Erica L Fletcher.   

Abstract

Huntington's disease (HD) is a progressive neurological disease characterised by motor dysfunction, cognitive impairment and personality changes. Previous work in HD patients and animal models of the disease has also highlighted retinal involvement. This study characterised the changes in retinal structure and function early within the progression of disease using the R6/1 mouse model of HD. The retinal phenotype was observed to occur at the same time in the disease process as other neurological deficits such as motor dysfunction (by 13 weeks of age). There was a specific functional deficit in cone response to the electroretinogram and using immunocytochemical techniques, this dysfunction was found to be likely due to a progressive and complete loss of cone opsin and transducin protein expression by 20 weeks of age. In addition, there was an increase in Müller cell gliosis and the presence of ectopic rod photoreceptor terminals. This retinal remodelling is also observed in downstream neurons, namely the rod and cone bipolar cells. While R6/1 mice exhibit significant retinal pathology simultaneously with other more classical HD alterations, this doesn't lead to extensive cell loss. These findings suggest that in HD, cone photoreceptors are initially targeted, possibly via dysregulation of protein expression or trafficking and that this process is subsequently accompanied by increased retinal stress and neuronal remodelling also involving the rod pathway. As retinal structure and connectivity are well characterised, the retina may provide a useful model tissue in which to characterise the mechanisms important in the development of neuronal pathology in HD.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22198376     DOI: 10.1016/j.nbd.2011.12.004

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  16 in total

Review 1.  Neuro-protection and neuro-regeneration of the optic nerve: recent advances and future directions.

Authors:  Kimberly K Gokoffski; Micalla Peng; Basheer Alas; Phillip Lam
Journal:  Curr Opin Neurol       Date:  2020-02       Impact factor: 5.710

2.  Optical coherence tomography findings in Huntington's disease: a potential biomarker of disease progression.

Authors:  Hannah M Kersten; Helen V Danesh-Meyer; Dean H Kilfoyle; Richard H Roxburgh
Journal:  J Neurol       Date:  2015-08-02       Impact factor: 4.849

3.  Retinal dysfunction in a presymptomatic patient with Huntington's disease.

Authors:  Jonelle Knapp; Dean A VanNasdale; Keith Ramsey; Julie Racine
Journal:  Doc Ophthalmol       Date:  2018-04-24       Impact factor: 2.379

4.  Contrast Acuity and the King-Devick Test in Huntington's Disease.

Authors:  Ali G Hamedani; Tanya Bardakjian; Laura J Balcer; Pedro Gonzalez-Alegre
Journal:  Neuroophthalmology       Date:  2019-11-25

Review 5.  Systemic manifestation and contribution of peripheral tissues to Huntington's disease pathogenesis.

Authors:  Chia-Lung Chuang; Fabio Demontis
Journal:  Ageing Res Rev       Date:  2021-05-09       Impact factor: 11.788

6.  Early retinal function deficit without prominent morphological changes in the R6/2 mouse model of Huntington's disease.

Authors:  Symantas Ragauskas; Henri Leinonen; Jooseppi Puranen; Seppo Rönkkö; Soile Nymark; Kestutis Gurevicius; Arto Lipponen; Outi Kontkanen; Jukka Puoliväli; Heikki Tanila; Giedrius Kalesnykas
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

7.  Attenuated pupillary light responses and downregulation of opsin expression parallel decline in circadian disruption in two different mouse models of Huntington's disease.

Authors:  Koliane Ouk; Steven Hughes; Carina A Pothecary; Stuart N Peirson; A Jennifer Morton
Journal:  Hum Mol Genet       Date:  2016-11-27       Impact factor: 6.150

8.  Evolution and expression plasticity of opsin genes in a fig pollinator, Ceratosolen solmsi.

Authors:  Bo Wang; Jin-Hua Xiao; Sheng-Nan Bian; Li-Ming Niu; Robert W Murphy; Da-Wei Huang
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

9.  Intravitreal administration of HA-1077, a ROCK inhibitor, improves retinal function in a mouse model of huntington disease.

Authors:  Mei Li; Douglas Yasumura; Aye Aye K Ma; Michael T Matthes; Haidong Yang; Gregory Nielson; Yong Huang; Francis C Szoka; Matthew M Lavail; Marc I Diamond
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

10.  Mutant huntingtin gene-dose impacts on aggregate deposition, DARPP32 expression and neuroinflammation in HdhQ150 mice.

Authors:  Douglas Young; Franziska Mayer; Nella Vidotto; Tatjana Schweizer; Ramon Berth; Dorothee Abramowski; Derya R Shimshek; P Herman van der Putten; Peter Schmid
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.